theverge.com/2022/1/25/22900608/pfizer-biontech-covid-vaccine-omicron-trial
Pfizer and BioNTech are launching a clinical trial to test an omicron-specific version of their COVID-19 vaccine, the companies announced today. They’re moving forward with studies of a new form of the vaccine in response to concerns that the original shot isn’t preventing infection with the newest variant of coronavirus or mild COVID-19 illness — even though it appears to be holding up well in terms of preventing hospitalization...
Posted by UE editors
Click to copy the Short Url to this post:
upo.st/vujutxxs 
Read the Entire Internet on a Single Page. Join Now →